−0.2840 USD
−4.72 M USD
0.00 USD
32.50 M
About BRIACELL THERAPEUTICS CORP
Sector
Industry
CEO
William V. Williams
Website
Headquarters
West Vancouver
Founded
2006
FIGI
BBG0018783B6
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where BCTX is featured.
Frequently Asked Questions
The current price of BCTX is 0.7700 USD — it has increased by 5.37% in the past 24 hours. Watch BriaCell Therapeutics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BriaCell Therapeutics Corp. stocks are traded under the ticker BCTX.
BCTX stock has fallen by −6.62% compared to the previous week, the month change is a −26.55% fall, over the last year BriaCell Therapeutics Corp. has showed a −82.70% decrease.
BCTX reached its all-time high on May 9, 2011 with the price of 611.7974 USD, and its all-time low was 0.4641 USD and was reached on Sep 16, 2024. View more price dynamics on BCTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BCTX stock is 35.89% volatile and has beta coefficient of 0.53. Track BriaCell Therapeutics Corp. stock price on the chart and check out the list of the most volatile stocks — is BriaCell Therapeutics Corp. there?
Today BriaCell Therapeutics Corp. has the market capitalization of 22.00 M, it has increased by 1.85% over the last week.
Yes, you can track BriaCell Therapeutics Corp. financials in yearly and quarterly reports right on TradingView.
BCTX net income for the last quarter is −1.20 M USD, while the quarter before that showed 1.69 M USD of net income which accounts for −171.24% change. Track more BriaCell Therapeutics Corp. financial stats to get the full picture.
No, BCTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BCTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BriaCell Therapeutics Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BriaCell Therapeutics Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BriaCell Therapeutics Corp. stock shows the sell signal. See more of BriaCell Therapeutics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.